powerpoint presentation · 2020-02-28 · us$ 670 bi - pharma us$ 9 bi - vaccines ... o inova...

29

Upload: others

Post on 30-May-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 2: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 3: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 4: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 5: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 6: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 7: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 8: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 9: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 10: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 11: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 12: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 13: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 14: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 15: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 16: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 17: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 18: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 19: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 20: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 21: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 22: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 23: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 24: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 25: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 26: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 27: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 28: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to
Page 29: PowerPoint Presentation · 2020-02-28 · US$ 670 bi - Pharma US$ 9 bi - Vaccines ... o INOVA Saúde Plan — Focus on innovation o Funding by FINEP, BNDES & Mol-I o Preference to